Data Safety Monitoring Committee (DSMC): The company announced completion of the fourth and final scheduled safety review by the DSMC for the ORCA-OL trial. Adverse events were mostly mild in severity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback